Bnp Paribas Asset Management Holding S.A. Gilead Sciences, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $40.3 Billion
- Q4 2024
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 1,811,613 shares of GILD stock, worth $198 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
1,811,613
Previous 764,520
136.96%
Holding current value
$198 Million
Previous $64.1 Million
161.07%
% of portfolio
0.41%
Previous 0.16%
Shares
30 transactions
Others Institutions Holding GILD
# of Institutions
2,101Shares Held
987MCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.6 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.84 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.6 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.33 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $137B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...